Enlaza Therapeutics is a startup based in the United States.
Enlaza Therapeutics is a company headquartered in the United States.
Enlaza Therapeutics develops biologic drugs using its War-LockTM technology, a synthetic biology platform that engineers biologics to irreversibly bind and lock to disease-related targets, aiming to enhance efficacy and safety.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.